ARYZTA (ARYN) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
2 May, 2026Executive summary
Revenue reached €2,223.3m for FY2025, with organic growth of 1.5% driven by both volume and price increases.
EBITDA was €306.9m with a margin of 13.8%, above guidance and reflecting resilience amid cost inflation.
Free cash flow totaled €120.0m, supporting a 5.7% increase in EPS to €4.25.
Leadership changes and board transitions planned, with a new Chair and permanent CEO to be appointed at AGM 2027; head office relocation to Zug subject to approval.
Strategic repositioning included customer negotiations, innovation driving 19% of revenue, and new capacity investments in Switzerland, Portugal, and Poland.
Financial highlights
Revenue increased to €2,223.3m from €2,194.5m year-over-year; organic growth was 1.5%.
EBITDA margin at 13.8% (down from 14.6% in 2024) due to input cost inflation, partially offset by pricing and cost savings.
Free cash flow conversion at nearly 40% of EBITDA.
EPS increased 5.7% to €4.25; ROIC at 12.1%, well above WACC of 8%.
Net debt to EBITDA improved to 2.6x; core equity ratio rose to 21.1% from 15.6%.
Outlook and guidance
Midterm plan targets: low-to-mid single-digit organic growth, EBITDA margin ≥15%, EBIT margin ≥9%.
CapEx to remain at 3.5%-4.5% of revenue; net debt leverage targeted at 1.5-2x.
Guidance for 2026: continued strong cash flow, stable financing costs (€40-43m), and further progress on capital return policy.
Board to publish capital return policy in 2026, with potential for dividends or share buybacks.
Plans to repurchase last remaining CHF 144.3m hybrid bond at next interest payment date.
Latest events from ARYZTA
- Revenue fell 2.7% to €1,063.9m, with margin resilience and capital returns planned for 2027.ARYN
H1 2026 - FY2025 targets exceeded, with strong EBITDA, cash flow, and major investment in Portugal.ARYN
Q4 2025 TU - Q3 organic growth 0.8%, YTD 2.1%, FY25 targets: €300m EBITDA, €100m free cash flow.ARYN
Q3 2025 TU - Leadership transition and 2025 EBITDA guidance reset to at least EUR 300m.ARYN
Investor Update - Revenue and EPS rose, with margin pressured by inflation but guidance reaffirmed.ARYN
H1 2025 - Innovation-led growth, margin expansion, and strong cash flow drive ARYZTA's robust performance.ARYN
Investor Presentation - EBITDA margin rose to 14.2% and leverage fell below 3x, driven by innovation and cost discipline.ARYN
H1 2024 - Targets above-market growth and >15% EBITDA margin by 2028 through innovation and efficiency.ARYN
CMD 2025 - Midterm targets met early, with higher margins, strong cash flow, and double-digit EPS growth.ARYN
H2 2024